postoperative pain
Conditions
Interventions
Control group:The drug 0.375% ropivacaine 20ml was used for brachial plexus block
Test group 1:The drug used was 0.375% ropivacaine 20ml+10mg dexamethasone for brachial plexus block
Test group 2:The drug 0.375% ropivacaine 28ml was used for brachial plexus block
Sponsors
The Third Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18 to 80 years; 2.ASA I - III level; 3.Subjects undergoing orthopedic surgery with elective open reduction and internal fixation for upper extremity fractures; 4.Voluntarily participate and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1.Preoperative complicated peripheral nerve injury or lesion; 2.Long-term oral painkillers for chronic pain; 3.Severe compound trauma; 4.Pregnant women; 5.A history of steroid use during the two weeks of the study; 6.There are contraindications to regional block; 7.Constrainations to dexamethasone (mental health disorders, cataracts, glaucoma, bacteraemia and systemic fungal infections, peptic ulcer disease, viral infections such as herpes or recent live vaccines); 8.Diabetic patients with a history of allergy to the study drug; 9.The wound is infected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog pain score;Systemic inflammation index was detected;Patient satisfaction;Surgeon satisfaction;15 item recovery quality score Scale;Pain Intensity and Opioid Consumption (PIOC) Score;Sleep quality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of sensory and motor nerve block; | — |
Countries
China
Contacts
Public ContactWang Qiujun
The Third Hospital of Hebei Medical University
Outcome results
None listed